Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study ; volume:14 ; number:1 ; day:5 ; month:8 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (5.8.2024), 1-10, 12.2024
- Urheber
-
Niu, Qinwang
Zhang, Tongtong
Mao, Rui
Zhao, Nana
Deng, Sui
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-69180-2
- URN
-
urn:nbn:de:101:1-2410252129595.088551378607
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Niu, Qinwang
- Zhang, Tongtong
- Mao, Rui
- Zhao, Nana
- Deng, Sui
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Genetic association of lipids and lipid lowering drug target genes with sarcoidosis
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Genetic association of lipids and lipid lowering drug target genes with sarcoidosis
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Genetic association of lipids and lipid lowering drug target genes with sarcoidosis
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea